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ABSTRACT
The core protein of hepatitis C virus (HCV) has been
shown previously to act as a potent nucleic acid
chaperone in vitro, promoting the dimerization of
the 30-untranslated region (30-UTR) of the HCV
genomic RNA, a process probably mediated by a
small, highly conserved palindromic RNA motif,
named DLS (dimer linkage sequence) [G. Cristofari,
R. Ivanyi-Nagy, C. Gabus, S. Boulant, J. P. Lavergne,
F. Penin and J. L. Darlix (2004) Nucleic Acids Res.,
32, 2623–2631]. To investigate in depth HCV RNA
dimerization,wegeneratedaseriesofpointmutations
in the DLS region. We find that both the plus-strand
30-UTR and the complementary minus-strand RNA
can dimerize in the presence of core protein, while
mutations in the DLS (among them a single point
mutation that abolished RNA replication in a HCV
subgenomic replicon system) completely abrogate
dimerization. Structural probing of plus- and minus-
strand RNAs, in their monomeric and dimeric forms,
indicate that the DLS is the major if not the sole deter-
minant of UTR RNA dimerization. Furthermore, the
N-terminal basic amino acid clusters of core protein
were found to be sufficient to induce dimerization,
suggesting that they retain full RNA chaperone
activity. These findings may have important con-
sequences for understanding the HCV replicative
cycle and the genetic variability of the virus.
INTRODUCTION
Hepatitis C virus (HCV) infection is a major health and eco-
nomic problem with >170 million people chronically infected
worldwide (1). In the majority ( 80%) of cases, HCV infec-
tion leads to viral persistence, eventually entailing serious
sequalae, including chronic hepatitis, steatosis, cirrhosis and
hepatocellular carcinoma (2). HCV is a small, enveloped
virus with a single-stranded RNA genome of positive polarity.
Based on its distinct features, it has been classiﬁed as the sole
member of the genus Hepacivirus in the Flaviviridae family
(3) which include two other genera with important human
and animal pathogens: ﬂaviviruses (e.g. West Nile virus, den-
gue virus, yellow fever virus) and pestiviruses (e.g. bovine
viral diarrhoea virus and classical swine fever virus). In addi-
tion, the Flaviviridae family include yet unassigned viruses
named GBV-A, GBV-B and GBV-C. GBV-B, the genetically
closest relative of HCV is hepatotropic and causes acute and
chronic hepatitis in New World monkeys (4,5).
The 9.6 kb genome of HCV contains a single long open
reading frame (ORF), ﬂanked by highly conserved 50- and
30-untranslated regions (50- and 30-UTRs). These regions are
highly structured and constitute cis-acting elements that play
essential roles in the viral replicative cycle [reviewed in
(6)]. The 50-UTR contains an IRES (internal ribosome entry
segment) that directs cap-independent translation of the viral
polyprotein (7,8), and an overlapping RNA signal that is
necessary for viral replication (9,10). The 30-UTR has a tri-
partite organization, being composed of a  40 nt long variable
region, a poly(U/UC) tract, and a highly conserved 98 nt seg-
ment, named X RNA (11–14). Except for the variable region,
30-UTR structures were shown to be necessary for viral
replication and productive infection (15–19). Translation of
the ORF yields a large polyprotein which is co-translationally
and post-translationally cleaved into at least 10 proteins: the
structural proteins (core, E1 and E2 glycoproteins), the
hydrophobic peptide p7 and the non-structural proteins NS2
to NS5B (20).
The core protein of HCV is a small ( 21 kDa), highly
basic RNA-binding protein generated in a mature form via
successive cleavages of the viral polyprotein (21–23). The
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doi:10.1093/nar/gkl240mature form of core is a dimeric alpha-helical protein exhib-
iting membrane binding properties via its C-terminal domain
D2 (24). The N-terminal part of core (domain D1) was shown
to bind to different regions of the HCV genomic RNA, as
well as to cellular RNA molecules (25–27). In the presence
of highly structured RNAs, such as tRNA or the 50-UTR of
HCV, recombinant core protein was sufﬁcient for particle
formation in vitro (28–31). Thus, core protein is believed to
bind the HCV genomic RNA, leading to genome packaging
and formation of the viral nucleocapsid. Besides its structural
role in the viral particle, core has also been implicated in a
variety of cellular processes, including regulation of gene
expression, cell apoptosis, signalling and lipid metabolism
(32–34).
Previously, we have shown that the core protein possesses
potent nucleic acid chaperone activities, similarly to retroviral
NC proteins (35). RNA chaperone proteins facilitate the
correct folding of RNA molecules by preventing their
misfolding or by resolving misfolded RNA species (36–38).
They bind nucleic acids with broad sequence speciﬁcity and
mediate RNA conformational changes in an ATP-independent
manner. In cells, a variety of proteins (e.g. hnRNP A1,
YB-1/p50, FMRP) carry out this essential function, thereby
regulating transcription, RNA processing, transport and
translation (37). RNA viruses also take advantage of RNA
chaperones for structural rearrangements necessary for the
translation and replication of their genomes. These proteins
are either encoded by the viruses themselves or ‘hijacked’
from the host cells, as in the case of the La protein, which is
utilized by numerous viruses—including HCV—to regulate
IRES-mediated translation (39,40). Viral-encoded RNA chap-
erones include also the small nucleocapsid (NC) proteins of
retroviruses that mediate critical structural rearrangements
of the retroviral genome required for replication and virus
assembly (41,42).
We have reported earlier that RNA chaperoning by core
results in important structural rearrangements of the 30-UTR
of the HCV genome, leading to RNA dimerization in vitro
(35). The RNA signal mediating dimerization involves a
16 nt long palindrome (named dimer linkage sequence or
DLS), located in the highly conserved 30 region, termed X
RNA. In this report, we further characterized the core protein-
mediated dimerization of the HCV UTR regions. We show
that both the plus-strand 30-UTR and the complementary
negative-strand RNA dimerize in the presence of the core
protein, and that the DLS is probably the sole determinant
of dimerization. Furthermore, based on enzymatic and chem-
ical probing of wild-type and mutant RNAs, we provide a
structural model for monomeric and dimeric X RNAs, and
propose a mechanism for the dimerization process.
MATERIALS AND METHODS
Plasmid DNA construction
Plasmid pSP64-30UTR was constructed by inserting a PCR
product [generated using pVan37 (35) and oligonucleotides
GAEL66 and SP6], containing a T7 promoter followed by
the 30-UTR region of HCV isolate Con1 (GenBank accession
no. AJ238799), between the SalI and HindIII sites of
pSP64 (Promega). The resulting plasmid thus contains the
HCV 30-UTR ﬂanked by T7 and SP6 promoters, making
possible the in vitro transcription of plus- and minus-strand
UTR RNAs, respectively. Point mutations were introduced
in pSP64-30UTR by using a PCR-based mutagenesis protocol
(43), with three common oligonucleotides (mut, SP6 and T7)
and one mutation-speciﬁc oligonucleotide (pal-1–pal-11) for
each mutant. To obtain plasmids containing the 30 X region,
plasmid pX(+) and pX(+)-Pal-4 were generated by PCR using
oligonucleotides PF1 and PF2, and plasmids pSP64-30UTR
and pMutPal-4, respectively. Plasmid pX( ) and pX( )-
Pal-4 were generated by PCR using oligonucleotides PF3
and PF4, and plasmids pSP64-30UTR and pMutPal-4, respect-
ively. The resulting PCR products were digested with EcoRI
and HindIII and ligated into pSP64-30UTR digested with the
same enzymes. For all PCRs, the Expand High Fidelity PCR
System (Roche Molecular Biochemicals) was used, and DNA
constructs were veriﬁed by sequencing. Oligonucleotides
used in this study are listed in Table 1.
In vitro RNA synthesis and purification
DNA templates for in vitro transciption of plus- and minus-
strand HCV RNAs were generated by digestion of the appro-
priate plasmids with HindIII or FokI, respectively. RNAs
were prepared by in vitro transcription with T7 or SP6
RNA polymerase, according to the manufacturer’s instruc-
tions (RiboMax kit, Promega), labelled by incorporation of
[
32P]UMP during in vitro transcription, and puriﬁed by
PAGE in 7 M urea, 50 mM Tris–borate, pH 8.3 and 1 mM
EDTA (0.5· TBE), followed by elution and ethanol precipita-
tion. Plasmids pX(+) and pX(+)-Pal-4 were linearized with
ScaI to generate templates for the in vitro synthesis of X(+)
and X(+)-Pal-4 RNAs, respectively. Plasmids pX( ) and
pX( )-Pal-4 were linearized with SmaI to generate templates
for the in vitro synthesis of X( ) and X( )-Pal-4 RNAs,
respectively. X RNAs were transcribed in vitro using the
T7-MEGAshortscript  high yield transcription kit (Ambion)
and puriﬁed by electrophoresis on a denaturing 12% PAGE as
described previously (44). RNAs were treated with calf
intestinal alkaline phosphatase (Roche Molecular Biochemic-
als) and 50 end-labelled using T4 polynucleotide kinase
(New England Biolabs) and [g-
32P]ATP. The 50 end-labelled
RNAs were puriﬁed by electrophoresis on a denaturing 12%
PAGE and recovered by elution, followed by ethanol
precipitation.
Protein expression and peptide synthesis
Full-length HCV core protein (amino acids 2–169) was
expressed in Escherichia coli and puriﬁed as described previ-
ously (24,35). Peptides 2BD and 3BD (Figure 3) were syn-
thesized on a Milligen 9050 apparatus with Fmoc-OH/DIC/
Hobt chemistry. The peptides were cleaved by a TFA solu-
tion with classical scavengers and precipitated in diethyl
ether. The precipitate was centrifuged and the pellet was solu-
bilized in water and lyophilised. The crude peptides were dis-
solved in water and puriﬁed on Vydac column (C18, 5 mm,
250 · 10 mm) in TFA 0.1% (A) with an appropriate gradient
of B (70% acetonitrile, 0.09% TFA). Puriﬁed peptides were
characterized by electrospray mass spectrum (SCIEX API
165) at 6696 and 9385 UMA for peptides 2BD and 3BD,
respectively, and by RP-HPLC on analytical column Vydac
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to 90% of B.
Dimerization assay
FL and/or X RNAs were incubated with proteins (at protein
to nucleotide molar ratios as indicated in the ﬁgure legends)
in 10 ml Core buffer (20 mM Tris–HCl, pH 7.0, 30 mM NaCl,
0.1 mM MgCl2 and 10 mM ZnCl2) containing 8 U RNasin
(Promega) at 37 C for 10 min. Reactions were stopped by
adding SDS–EDTA solution (at 0.5% SDS and 5 mM
EDTA ﬁnal concentrations). Proteins were removed by pro-
teinase K digestion (2 mg) at room temperature for 15 min.
RNAs were phenol-chloroform extracted and analysed by
PAGE under native conditions, followed by autoradiography.
Analysis of the thermal stability of dimeric RNAs
X(+) RNA or X( ) RNA (8 pmol) were incubated in the
presence of 3BD (40 pmol) and 64 U RNasin (Promega)
for 10 min at 37 C in a ﬁnal volume of 80 ml Core buffer.
RNAs were recovered by phenol-chloroform extraction.
Aliquots (10 ml) of each sample were incubated for 7 min
at temperatures ranging from 20 to 65 C, followed by
addition of 2.5 ml of loading buffer (50 w/v% glycerol,
0.05 w/v% bromophenol blue, 0.05 w/v% xylene cyanol).
The aliquots were loaded on 1.5% agarose (Seakem LE
agarose) gel and electrophoresis was carried out at 20 Ci n
0.5· TBE buffer. The percentage of dimerization was determ-
ined as described previously (45). The labelled RNA was
detected by autoradiography as described previously (45)
and quantiﬁed with a Storm 840 (Molecular Dynamics).
Enzymatic RNA probing
Assays were carried out in a ﬁnal volume of 10 ml.
32P-labelled
RNA (1 pmol) was dissolved in 6 ml of water, heated at 90 C
for 1 min and chilled on ice. Then, 8 U RNasin and Core
buffer were added (ﬁnal concentrations: 20 mM Tris–HCl,
pH 7.0, 30 mM NaCl, 0.1 mM MgCl2 and 10 mM ZnCl2)
and the sample was incubated in the presence or absence of
3BD (5 pmol) for 10 min at 37 C. RNA was recovered by
phenol-chloroform extraction when 3BD was removed
before enzymatic probing. To equalize the quantity of RNA
in each assay, 1 mg of a tRNA mixture from E.coli MRE
600 (Roche Molecular Biochemicals) was added to the
sample before the addition of a ribonuclease. RNA was
incubated with RNases T1 (Life Technologies), T2 (Life
Technologies) or V1 (Ambion) for 7 min at 37 C. The
cleavage reactions were stopped by extraction with phenol-
chloroform followed by precipitation in ethanol. The dry
pellets were dissolved in 7 M urea, 0.03 w/v% bromophenol
blue and 0.03 w/v% xylene cyanol and loaded on denaturing
10 or 12% polyacrylamide gels. The cleavage sites were
identiﬁed by running in parallel the products of alkaline
hydrolysis and limited RNase T1 digestion of the same
RNA. Alkaline hydrolysis was performed at 90 C for 5 min
in 45 mM NaHCO3/Na2CO3 (pH 8.9). Partial RNase T1
digestion was performed with 0.1 U of the enzyme at 50 C
for 5 min in 13 mM sodium citrate (pH 5), 3 M urea, 0.6
mM EDTA, 0.03 w/v% bromophenol blue and 0.02 w/v%
xylene cyanol.
Chemical RNA probing with CMCT
1-Cyclohexyl-3-(2-morpholinoethyl) carbodiimide metho-
p-toluene sulfonate (CMCT) was purchased from
Sigma–Aldrich. Assays were carried out in a ﬁnal volume
of 10 ml. RNA (1 pmol) was dissolved in 6 ml of water, heated
at 90 C for 1 min and chilled on ice. Then, 8 U RNasin and
probing buffer were added (ﬁnal concentrations: 20 mM
HEPES–KOH, pH 7.8, 30 mM NaCl, 0.1 mM MgCl2 and
10 mMZ n C l 2) and the sample was incubated in the presence
or absence of 3BD (5 pmol) for 10 min at 37 C. RNA was
recovered by phenol-chloroform extraction when 3BD was
removed before CMCT probing. To equalize the quantity
of RNA in each assay, 1 mg of a tRNA mixture from
E.coli MRE 600 (Roche Molecular Biochemicals) was
Table 1. Oligonucleotides used in this study
Name Sense Sequence (50 to 30)
GAEL66 (+) GGGCTCGAGTAATACGACTCACTATAGGGACGGGGAGCTAAACACTCCAGGCC
mut (+) CAGAGGAGCAGGCCAATAGGCCATC
SP6 ( ) TATTTAGGTGACACTATAG
T7 (+) TAATACGACTCACTATAGGG
pal-1 ( ) GGACCTTTCACtGgTAGCCGTGACT
pal-2 ( )T T TCACAGCTAGgCGTcACTAGGGCTAAG
pal-3 ( ) TCACGGACCTTaCACAGCTAGCC
pal-4 ( ) ACCTTTCACAGgTAGCCGTGACT
pal-5 ( ) ACCTTTCACAGaTAGCCGTGACT
pal-6 ( ) CTTTCACAGCTAtCCGTGACTAGG
pal-7 ( ) CTTTCACAGCTAcCCGTGACTAGG
pal-8 ( ) ACCTTTCACAGCaAGCCGTGACTA
pal-9 ( ) ACGGACCTTTCtCtGCTAGCaGaGACTAGGGCTA
pal-10 ( ) GGCTCACGGAggTTTCACAGCTAGCCGTGACTAGacCTAAGATGGAGC
pal-11 ( ) GGCTCACGGAggTTTCACAGgTAGCCGTGACTAGacCTAAGATGGAGC
PF1 (+) GAAGAATTCTGGAGTAATACGACTCACTATAGGTGGCTCCATCTTAG
PF2 ( ) CCGACGCCAAGCTTAGTACTTGATCTGCAGAGAG
PF3 ( ) GAAGAATTCTGGAGTAATACGACTCACTATAGACTTGATCTGCAGAGAG
PF4 (+) CATGACAAGCTTCCCGGGTGGCTCCATCTTAG
PF5 ( ) CAGTCAAGCGGCTCACG
PF6 (+) GGTGGCTCCATCTTAGC
Mutations introduced in the X RNA region are in lower case. The T7 promoter sequence is underlined and the DLS is in boldface.
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incubated with 17 mg/ml of CMCT for 5 and 10 min at 37 C.
The CMCT treatment was stopped by adding 30 ml ethanol
and 1 ml of 3 M sodium acetate. After ethanol precipitation,
the dry pellet was dissolved in water and the modiﬁed bases
were identiﬁed by primer extension with avian myelo-
blastosis RT (Invitrogen) as described previously (46).
ODN PF5 complementary to X(+) and X(+)-Pal-4
RNAs, and PF6 complementary to X( ) and X( )-Pal-4
RNAs were used as primers and were 50 end-labelled using
T4 polynucleotide kinase and [g-
32P]ATP. The samples
were analysed by electrophoresis on a denaturing 8%
polyacrylamide gel.
RESULTS
Core protein mediates dimerization of plus- and
minus-strand HCV RNAs in vitro
Previously, we have shown that a 16 nt long palindrome
(50-UCACGGCUAGCUGUGA-30; Figure 1B and C) is
involved in the dimerization of the HCV plus-strand
30-UTR (35). By analogy with retroviruses, we named this
palindromic region DLS. This RNA motif is universally
present in the X RNA region (Figure 1A and B) of all
HCV sequences reported so far, suggesting that it plays an
important role in the viral life cycle.
Since HCV replicates via a negative-strand RNA interme-
diate, which in turn serves as a template for plus-strand
RNA synthesis, we examined whether the minus-strand
genomic RNA would be also able to dimerize. RNAs corres-
ponding to the full-length plus-strand 30-UTR or to the com-
plementary minus-strand RNA [FL(+) and FL( ),
respectively], and to the X regions [X(+) and X( ) RNAs]
were synthesized by run-off transcription and incubated for
10 min at 37 C in the presence of increasing concentrations
of core protein. After dissociation of the core from the
RNA by extensive proteinase K digestion and SDS treatment
prior to phenol-chloroform extraction, RNAs were resolved
on a native polyacrylamide gel (Figure 1D). Incubation
with core protein induced the appearance of a new RNA
species both for FL(+) and FL( ) (Figure 1D, lanes 1–5),
as well as for X(+) and X( ) RNAs (Figure 1D, lanes
6–10). The resulting bands likely correspond to a new
structural form of the RNA molecules induced by the
interaction with the core protein. Accordingly, when FL
and X RNAs were incubated together with core protein
(Figure 1D, lanes 11–15), a new intermediate-sized band
appeared, corresponding to FL-X heterodimers. These data
clearly demonstrate that the slowly migrating RNA forms
result from dimerization of the UTR RNAs, induced by the
core protein.
Analysis of the thermal stability of dimeric RNAs showed
that the X(+) RNA dimers are more stable than the X( )
RNA dimers. Indeed, the X(+) dimers melt at 55–60 C
while the X( ) dimers melt at  50 C (Supplementary
Figure 1). This may be due to mismatches in the minus-strand
DLS dimer (Figure 1C).
Sequence determinants for HCV RNA dimerization
In order to map the major determinants of HCV UTR RNA
dimerization, we introduced point mutations at various posi-
tions in the DLS and monitored the dimerization of the result-
ing UTR (FL) RNAs at increasing core protein/RNA molar
ratios. The mutations and their inﬂuence are summarized in
Figure 2A. Representative results are shown for FL(+)
RNAs in Figure 2B and for FL( ) RNAs in Figure 2C.
Based on the most stable FL(+) RNA structure predicted
by the Mfold program version 3.2 (47), the DLS(+) forms
an apical stem–loop (Figure 1B, right-hand structure and
Figure 2A) where the central [29CUAG32] is unpaired,
while the two ends of the palindrome constitute the stem.
Importantly, even single point mutations in the loop com-
pletely abolished core-mediated dimerization [Figure 2B,
Pal-4(+)–Pal-7(+)], except for Pal-8(+) where the RNA with
a[ 29CUUG32] loop was still able to dimerize, albeit with
reduced efﬁciency. In Pal-8(+), formation of non-canonical
U–U base pairs may account for the observed dimerization.
Indeed, in internal loops closed by G–C base pairs, U–U
pairs may be stabilizing by forming hydrogen bonds (48).
Moreover, complementarity in the DLS(+) stem is also
important for dimerization, as evidenced by Pal-2(+) which
did not dimerize upon disruption of the stem. In contrast,
when complementarity is preserved by introducing symmet-
rical mutations [Pal-9(+)], or by trans-complementation
(Supplementary Figure 2), dimerization still occurred. Inter-
estingly, we observed a slight, but nevertheless reproducible
decrease in the dimerization efﬁciency of Pal-9(+) RNA com-
pared with the wild type. This may be due to the stabilization
of the monomeric structure [ 7.4 kcal/mol calculated for the
region 23–38 in Pal-9(+) compared with  6.5 kcal/mol for
the wild type] by changing a G–U base pair to A–U, resulting
in a higher energy barrier for the disruption of the original
base pairing.
The profound effect of mutations observed both in the stem
and in the loop region indicate formation of an extended
duplex and suggest that a ‘kissing loop’ interaction alone is
not sufﬁcient for stable dimerization. In agreement with
this, we were unable to observe dimerization of wild-
type(+) RNA in the presence of 5 mM Mg
2+ and migration
at 4 C, conditions described to facilitate kissing loop
formation and stabilization (49).
The most stable predicted structure for DLS( ) consists of
an 8 nt loop and a shorter stem than for the complementary
sequence. Nevertheless, dimerization of mutant FL( )
RNAs (Figure 2C) mirrored the pattern observed for the
FL(+) RNAs, indicating that the same determinants play a
role in DLS(+) and DLS( ) RNA dimerization.
Core domains promoting HCV RNA dimerization
The HCV core protein consists of a basic N-terminal RNA
binding domain with three highly charged amino acid clusters
(Figure 3A), and a hydrophobic C-terminal domain that is
probably involved in the intracellular targeting of the protein
to lipid droplets (24,50–52). The N-terminal region (amino
acids 2–117) alone proved to be active in RNA chaperone
assays and promoted UTR dimerization efﬁciently [(35)
and data not shown]. To gain further insights into the determ-
inants of core chaperoning, we examined the nucleic acid
chaperone activity of the N-terminal basic clusters of
HCV core protein. Peptides 3BD and 2BD, corresponding
to all three or the second and third highly basic clusters,
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Figure 1. (A) Organization of the HCV genome. The three regions of the 30-UTR [variable region, poly(U/UC) tract and X RNA] are illustrated in the inset. (B)
AlternativestableconformationsofXRNA,predictedbytheMfoldprogram(47).Thepalindromicregionisillustratedinboldfaceonagreybackground.Numbering
beginsatthe50 firstnucleotideoftheXRNA.(C)DLS(+)andDLS( )sequences,illustratingthepotentialbasepairinginteractionsinthedimericform.Numbering
begins at the 50 end of X(+) and X( ) RNA, respectively. (D) Heterodimerization of plus-strand full-length 30-UTR [FL(+)] and X(+) RNAs, and of the
complementary minus-strand RNA regions [FL( ) and X( )] in the presence of core protein. The full-length UTR (lanes 1–5), X RNA (lanes 6–10), or both
(lanes11–15)wereincubatedwiththecoreproteinatproteintonucleotidemolarratiosof0,1:80,1:40,1:20and1:10.After10minincubationat37 C,coreprotein
was removed by SDS treatment and proteinase K digestion and RNA were analysed by native gel electrophoresis and autoradiography.
2622 Nucleic Acids Research, 2006, Vol. 34, No. 9Figure 2. Influence of DLS mutations on HCV RNA dimerization. (A) Mutations introduced in the X RNA region, and their effect on plus-strand 30-UTR and
complementaryminus-strandRNAdimerization.Mutationsarehighlightedwithblackbackgroundcircles.Forthesakeofclarity,potentialconformationalchanges
in the DLS resulting from the mutations are not illustrated here (for details see Supplementary Figure 3). Numbering begins at the 50 end of X(+) and X( ) RNA,
respectively.(B)Dimerizationofwild-typeandmutantFL(+)RNAs.
32P-labelledRNAmoleculeswereincubatedwithincreasingamountsofcoreprotein(atprotein
to nucleotide molar ratios of 0, 1:80, 1:40 and 1:20). Following incubation, core protein was removed and RNA were analysed by native gel electrophoresis and
autoradiography. FL(D) corresponds to dimeric RNA, while FL(M) to the monomeric form. (C) Dimerization of wild-type and mutant FL( ) RNAs. Experiments
were done as in (B).
Nucleic Acids Research, 2006, Vol. 34, No. 9 2623respectively (Figure 3A), were chemically synthesized and
puriﬁed as described in Materials and Methods.
Dimerization of wild-type FL(+) RNA was monitored at
increasing peptide to nucleotide molar ratios (Figure 3B).
Intriguingly, the ability of 2BD and 3BD to dimerize HCV
UTR RNAs was close to or equal, respectively, to that of
the full-length core protein. Importantly, this dimerization
reﬂects the RNA chaperone activity of the peptides, and
cannot be accounted for by simple charge neutralization,
since a highly basic peptide (pI ¼ 9.9) lacking chaperone
activity was not able to direct FL(+) dimerization (35).
Experimental strategy for the structural
probing of the HCV X RNAs
In order to better understand the mechanism of core-mediated
dimerization, we analysed the structure of wild-type plus- and
minus-strand X RNAs in their monomeric and dimeric forms.
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Figure 3. Activityof core peptides in RNA dimerization. (A) The barchart illustratesthe chargedistribution ofamino acids in the core protein,as calculatedby the
chargefunctionoftheEMBOSSpackage,usingdefaultparametersandaslidingwindowoffiveaminoacids.Syntheticpeptides2BDand3BDcorrespondtotwoor
three basic amino acid clusters of the core protein, respectively. (B) Dimerization of FL(+) RNAs induced by core peptides 2BD and 3BD.
32P-labelled RNA
moleculeswereincubatedwithincreasingamountsofthecorrespondingpolypeptides(atpolypeptidetonucleotidemolarratios1:80,1:40,1:20and1:10).Following
incubation,polypeptideswereremovedandRNAwereanalysedbynativegelelectrophoresisandautoradiography.FL(D)correspondstodimericRNA,whileFL(M)
to the monomeric form.
2624 Nucleic Acids Research, 2006, Vol. 34, No. 9In parallel experiments, we also analysed the structure of a
dimerization-deﬁcient mutant RNA (Pal-4) which was selec-
ted because this point mutation completely abolishes HCV
replication in a subgenomic replicon system (18). All four
RNAs, in the presence or absence of the 3BD peptide, were
probed with RNases T1, T2 and V1 at 37 C under conditions
described in Materials and Methods. We used the 3BD pep-
tide for the probing experiments for several reasons. Firstly, it
was available in quantities large enough to perform several
times the experiments. Secondly, the core basic clusters
behave similarly to the full-length core with respect to
RNA binding (data not shown), 30-UTR dimerization
(Figure 3B) and capsid assembly (30). Since the N-terminal
region of core protein is essentially unfolded in the absence
of RNA (24,53), deletion of the linker regions between the
basic clusters probably does not change the structure of the
core protein–RNA complex.
RNase T1 is speciﬁc for unpaired guanines, while RNase
T2 cleaves single-stranded regions with a preference for
adenines and RNase V1 is speciﬁc for double-stranded and
stacked regions. The cleavage positions were identiﬁed
using 50 end-labelled RNAs. To investigate the DLS, we
also used CMCT that modiﬁes N3 position of uridines and,
at lower rate, N1 position of guanines. The modiﬁed bases
were identiﬁed by primer extension (Materials and Methods).
Representative examples of probing experiments are shown
in Figures 4 and 6, and the results of a series of independent
experiments are summarized in Figures 5 and 7. To generate
the secondary structural models, we selected the foldings pre-
dicted by the Mfold program (47) that were the most consist-
ent with the experimental data.
To identify possible conformational changes and protec-
tions induced by 3BD in the X region, we compared the
enzymatic and CMCT probing patterns of the four RNAs in
the presence or absence of 3BD. To discriminate between
reactivity changes induced by RNA dimerization and those
resulting from the binding of 3BD, enzymatic and CMCT
probings of wild-type RNAs were also performed after
removal of 3BD by extraction with phenol-chloroform. We
veriﬁed that after phenol-chloroform extraction and incuba-
tion at 37 C, the temperature used for RNA probing, the
dimers did not dissociate (Supplementary Figure 1).
Structural probing of wild-type X(+) and
mutant X(+)-Pal-4 RNAs
The probing data are consistent with the formation of stem–
loop SL1 and a structural heterogeneity for the 1–20 sequence
in the X(+) and X(+)-Pal-4 RNAs under both the monomeric
and dimeric forms (Figure 5). Furthermore, as observed pre-
viously (54,55), our probing data support a structural hetero-
geneity for the 21–55 region of the monomeric X(+) RNA
(Figure 5A). Interestingly, we found that 3BD induced a sig-
niﬁcant increase in RNase T1 sensitivity for G46 and G48, and
a strong decrease in RNase T1 sensitivity for guanine resi-
dues in the DLS of the X(+) RNA (Figure 4A, lanes 3BD).
In addition, new RNAse V1 cleavages sites (G28,U 30,C 33
and U34) appeared in the DLS upon incubation with 3BD.
The RNase cleavage patterns of the dimeric X(+) RNA,
following removal of 3BD, were identical to those obtained
in the presence of 3BD (Figure 4A, compare lanes 3BD
and 3BD rm), in agreement with the proposed chaperoning
role of core, where the protein is only required to establish
the dimer but not to maintain it. Taken together, our results
support a secondary structural model in which the reactivity
changes are caused only by RNA dimerization through the
DLS (Figure 5B).
In contrast with the wild-type sequence, the probing data
suggest that the 21–55 region in the monomeric X(+)-Pal-4
RNA forms a unique stem–loop structure (Figure 5C),
which is not changed in the presence of the 3BD peptide.
Thus, a possible explanation for the inability of Pal-4
RNAs to dimerize could be that the DLS is ’trapped’ in a con-
formation favouring the monomeric structure. In order to dis-
criminate between the effects of sequence versus structural
changes on dimerization, we introduced additional point
mutations in Pal-4 outside the DLS region that would
strongly favour formation of the alternative SL2 structure,
where the DLS(+) constitutes an apical stem–loop (Pal-11
RNA in Supplementary Figure 4). However, the second-site
mutations did not restore dimerization of the 30-UTR, indicat-
ing that correct folding and DLS sequence both play a role in
dimerization.
Structural probing of wild-type X( ) and
mutant X( )-Pal-4 RNAs
The probing data are consistent with the proposed secondary
structural models for the X( ) and X( )-Pal-4 RNAs
(Figure 7A and C). Interestingly, we found that 3BD induced
a strong decrease in RNase T1 and T2 sensitivity for G67,
G71,G 76,U 69 and A70 that lie within the DLS of the X( )
RNA (Figure 6A, lanes 3BD, and Figure 7A). In addition,
new RNAse V1 cleavage sites (U69,C 73 and A80) appeared
upon incubation with 3BD or in the dimeric X( ) RNA
after removal of 3BD (Figure 6A, lanes 3BD, and 3BD
rm). V1 cleavage at U69 and C73 is compatible with the
formation of an extended duplex that links the two subunits
in the dimeric RNA (Figure 7B). However, our probing
data do not exclude the possibility that the linkage structure
is restricted to a loop–loop complex involving the DLS
sequence. It was surprising that moderate T1 and T2 cleav-
ages occurred within the DLS when 3BD was extracted
from the dimer (Figure 6A). A possible explanation is that
3BD stabilizes the extended duplex that contains two mis-
matches. The helix between the mismatches may become
less stable and more sensitive to single-strand speciﬁc
RNases after removal of the core peptide.
In the structure of the X( )-Pal-4 RNA, G91 and G92 are
predicted to lie within a short stem, but they were a moderate
T1 target (Figure 7C). This observation suggests that the
base pairing interaction between nucleotides 78CUA80 and
90UGG91 is transient. The RNase cleavage patterns of the
X( )-Pal-4 RNA were not changed in the presence of 3BD
(Figure 6B).
DISCUSSION
RNA chaperone activity of HCV core protein
and X RNA dimerization
The HCV core protein was found to bind nucleic acids in a
relatively sequence-independent manner and to chaperone
Nucleic Acids Research, 2006, Vol. 34, No. 9 2625Figure4.Enzymaticprobingofwild-typeX(+)RNA(A)andX(+)-Pal-4RNA(B).50 End-labelledRNAsintheabsence(lanes 3BDand3BDrm)orinthepresence
of3BD(lanes3BD)wereincubatedwithRNasesT1[0.06(lanesC1)and0.12(lanesC2)unit],T2[0.06(lanesC1)and0.12(lanesC2)unit]orV1[0.006(lanesC1)and
0.012(lanesC2)unit]asdescribedinMaterialsandMethods.LanesC0arecontrolswithoutRNasetreatment.The3BDtonucleotidemolarratiowas1:20.Forlanes
3BDrm,3BDwasremovedbeforeenzymaticprobing.TandLrefertoRNAseT1sequencingandtothealkalineladder,respectively.Arrowspointoutthecleavage
sites. The reactivity changes induced by RNA dimerization are indicated by asterisks.
2626 Nucleic Acids Research, 2006, Vol. 34, No. 9Nucleic Acids Research, 2006, Vol. 34, No. 9 2627the formation of the most stable nucleic acid structure in
vitro, as evidenced by strand annealing (hybridization) and
strand exchange assays (35). Upon binding to its partner,
the genomic RNA of HCV, the core protein triggered import-
ant structural rearrangements, inducing the dimerization of
the plus-strand 30-UTR, and also that of the complementary
minus-strand RNA region. Importantly, once the dimeric
RNA conformation has been reached, core protein was no
longer necessary to maintain the newly formed structure, con-
ﬁrming a bona ﬁde chaperone function. Furthermore, the
N-terminal basic amino acid clusters of core protein were
found to retain nucleic acid chaperone activity and induce
dimerization of the UTR RNAs (Figure 3B). Indeed, the
N-terminal part of the protein was shown previously to be
sufﬁcient for RNA-binding (25) and particle formation
(28,29,31), and uncharged regions connecting the basic
clusters were found to be dispensable for assembly (30),
indicating that RNA chaperoning and capsid assembly
require the same core protein regions.
Mutational analysis and structural probing of plus- and
minus-strand X RNAs (Figures 2, 4 and 6 and Supplementary
Figure 4) provided strong evidence that dimerization is medi-
ated by a 16 nt long palindromic sequence, the DLS. Muta-
tions disrupting the palindromic nature of the DLS
completely abolished UTR dimerization, while a mutant
RNA preserving self-complementarity dimerized efﬁciently
(Figure 2). Besides changing the DLS sequence, the muta-
tions could also inﬂuence dimerization efﬁciency by modify-
ing the conformation of the DLS region, or by altered core
protein binding properties. Despite our attempts, we could
not detect signiﬁcant differences in core protein binding afﬁn-
ity for wild-type versus mutant UTR RNAs (data not shown).
However, Mfold analyses (Supplementary Figures 3 and 4)
and structural probing of a dimerization-incompetent mutant
RNA (Pal-4) (Figures 4 and 6) show that the mutations may
change the conformation of the DLS region or skew the
equilibrium between co-existing alternative conformations.
Overall, our results support a mechanism whereby both
RNA sequence and structure are important determinants of
core-mediated viral RNA dimerization.
Conformational changes in X RNA
The 98 nt long X RNA constituting the 30 end of the HCV
genome is extremely conserved between HCV genotypes
(56) and is required for virus replication in cell culture (17–
19) and in the chimpanzee (15,16). Besides replication, roles
in translational regulation and RNA stability have also been
proposed for the X RNA (57–59) but these issues still remain
controversial (17,60).
Based on chemical and enzymatic probing of plus- and
minus-strand X RNAs, we propose structural models for
their monomeric and dimeric forms (Figures 5 and 7). A
plausible mechanism for dimerization would be that core pro-
tein binds to (transiently) single-stranded RNA regions and
prevents their immediate re-annealing. This metastable struc-
ture could then be stabilized by either regaining the mono-
meric conformation, or by the thermodynamically favoured
dimerization. At the moment, we cannot distinguish between
potential alternative (loop–loop, stem–loop or stem–stem)
dimerization mechanisms.
Due to its importance in HCV replication, the conforma-
tion of X RNA has been extensively studied (54–55,61–63)
and it was suggested to adopt several alternative conforma-
tions, including two different pseudoknot interactions invol-
ving the DLS region (63,64). Friebe and co-workers
suggested that nucleotides [32GCUGUGA38] in SL2 would
form a pseudoknot with a complementary sequence in a con-
served stem–loop structure (5BSL3.2) in the NS5B region of
the HCV genome (64). Mutations in either SL2 or 5BSL3.2
abolished replication of a subgenomic replicon, while com-
pensatory mutations restoring the proposed base pairing res-
cued replication, albeit only at low level [i.e. 50-fold less than
for the wild-type replicon construct, (64)]. Importantly, all
structural (and subgenomic replicon) studies so far have
been conducted in the absence of the core protein. Our results
showing profound structural rearrangements in the X RNA
region upon core protein binding argue for a functional relev-
ance for the structures proposed in Figures 5 and 7. Indeed,
RNA molecules encompassing both the NS5B and 30-UTR
regions of HCV dimerize efﬁciently upon core protein bind-
ing (data not shown), indicating that the dimeric form, at least
in vitro, is favoured over the pseudoknot structures in the
presence of the core protein. Thus, pseudoknot formation
would probably occur only at the beginning of the replicative
cycle, when core protein levels are still low. Then, concom-
itant with the accumulation of core, the more stable dimeric
conformation would become predominant.
Although the exact role of these alternative conformations
is still poorly understood, it is tempting to speculate that inter-
conversions between the various forms—including the mono-
meric and dimeric RNAs, as well as the proposed pseudoknot
structures—constitute an elaborate system of riboswitches
that regulate major transitions between translation/replication
and replication/packaging of the viral RNA (54–55,63). Since
RNA chaperones, including core, have been shown to exert
their effect on RNA transconformations in a highly
concentration-dependent manner (35), gradual core protein
accumulation following infection could be a major driving
force in orchestrating the various switches. Moreover, as
numerous other cellular and viral proteins have been described
to bind to the X RNA region of the HCV genomic RNA,
including polypyrimidine-tract binding protein, several
Figure5.SecondarystructuremodelsfortheHCVX(+)RNAs.Closed,greyandopensymbolsindicatestrong,mediumandweakcleavagesites,respectively,forthe
variousRNases(circleforT1,triangleforT2anddiamondforV1).Thecolourcodesusedforthereactivityofuridinesisindicatedintheinset.Theabsenceofcolour
indicates thatthe reactivityofthe givennucleotidecouldnotbedeterminedbecauseof the presenceof a band in the controllane. Thereactivityofnt 45–98towards
CMCThasnotbeendetermined.Thereactivitychangesbetweenthemonomericanddimericconformationsareindicatedbyasterisks.Inthemonomericanddimeric
conformationsoftheX(+) RNAandX(+)-Pal-4RNA,the53–98sequenceformsstem–loopSL1,andthe1–20sequence (dottedinset)formsstem–loopSL3andan
alternative secondary structure that are in a dynamic equilibrium. (A) Monomeric conformations of X(+) RNA. The reactivities of nucleotides towards CMCT and
RNases were determined in the absence of 3BD. The 1–55 sequence forms stem–loops SL2 and SL3, and alternative secondary structures that are in a dynamic
equilibrium. (B) Dimeric conformations of X(+) RNA. The reactivities of nucleotides towards CMCT and RNases were determined after removal of 3BD. The
extended duplex is formed by the 23–38 sequence of two X(+) RNA molecules. Only the extended duplex and one strand of the dimer are drawn. (C) Monomeric
conformations of X(+)-Pal-4 mutant RNA in the absence or presence of 3BD.
2628 Nucleic Acids Research, 2006, Vol. 34, No. 9Figure 6. Enzymatic probing of wild-type X( ) RNA (A) and X( )-Pal-4 RNA (B). 50 End-labelled RNAs in the absence (lanes  3BD and 3BD rm) or in the
presenceof3BD(lanes3BD)wereincubatedwithRNasesT1[0.03(lanesC1),0.06(lanesC2)and0.12(lanesC3)unit],T2[0.03(lanesC1),0.06(lanesC2)and0.12
(lanesC3)unit]orV1[0.006(lanesC1)and0.012(lanesC2)unit]asdescribedinMaterialsandMethods.LanesC0arecontrolswithoutRNasetreatment.The3BDto
nucleotide molar ratio was 1:20. For lanes 3BD rm, 3BD was removed before enzymatic probing. T refers to RNAse T1 sequencing. Arrows point out the cleavage
sites. The reactivity changes induced by 3BD are indicated by asterisks.
Nucleic Acids Research, 2006, Vol. 34, No. 9 2629Figure 7. Secondary structure model for the X( ) RNAs. Closed, grey and open symbols indicate strong, medium and weak cleavage sites, respectively, for the
variousRNases(circleforT1,triangleforT2anddiamondforV1).Thecolourcodesusedforthereactivityofuridinesareindicatedintheinset.Theabsenceofcolour
indicatesthatthereactivityofthegivennucleotidecouldnotbedeterminedbecauseofthepresenceofabandinthecontrollane.Thereactivityofnt83–100towards
CMCT has not been determined. In the monomeric and dimeric conformations of the X( ) and X( )-Pal-4 mutant RNAs, the 3–46 sequence forms the SL1( )
stem–loop. (A) Monomeric conformation of X( ) RNA. The reactivities of nucleotides towards CMCT and RNases were determined in the absence of 3BD. The
reactivitydecreasesinducedby3BDareindicatedbyasterisks.(B)DimericconformationofX( )RNA.ThereactivitiesofnucleotidestowardsCMCTandRNases
weredeterminedinthepresenceof3BD.Thereactivityincreasesinducedby3BDareindicatedbyasterisks.Theextendedduplexisformedbythe62–77sequenceof
twoX( )RNAmolecules.Onlytheextendedduplexandonestrandofthedimeraredrawn.(C)MonomericconformationofX( )-Pal-4mutantRNAintheabsence
or presence of the 3BD peptide.
2630 Nucleic Acids Research, 2006, Vol. 34, No. 9ribosomal proteins, and the viral non-structural NS3 and
NS5B proteins (58,65–68), the actual conformational state
of X RNA—and the resulting function—would probably
reﬂect the complex interplay of these proteins.
Interestingly, RNA chaperone-mediated remodelling of
regulatory regions in genomic RNA seems to be a widespread
strategy employed by distant virus families to regulate
diverse steps of the viral life cycle. The best known
example is the nucleocapsid (NC) protein of retroviruses
and retroelements, which is instrumental in virus structure,
genomic RNA replication, dimerization/packaging, and
recombination (42). Moreover, the nucleocapsid (N) protein
of hantaviruses (segmented negative-sense RNA viruses of
the Bunyaviridae family) has also been suggested to act as
an RNA chaperone, binding with high afﬁnity the terminal
panhandle structures (69).
Possible consequences of HCV RNA dimerization
on viral variability
The status of HCV genomic RNA, i.e. if it is monomeric or
dimeric, either in infected cells or in virions, is currently
unknown. Lack of efﬁcient cell culture systems producing
infectious viruses had for long time precluded studies
aimed at understanding viral assembly and structure. With
the recent development of cell culture models supporting
complete replication of HCV (70–72), these studies became
possible, and we are currently investigating the role of
RNA dimerization in HCV replication and packaging.
Nevertheless, several independent pieces of evidence support
an important role for core protein chaperoning and RNA
dimerization in the viral life cycle: (i) the DLS is completely
conserved in all reported HCV sequences, and mutations in it
abolish replication (18,64); (ii) the core proteins of related
viruses (such as the ﬂavivirus WNV, the pestivirus BVDV,
and GBV-B, an unclassiﬁed virus most closely related to
HCV) all show potent RNA chaperone activities in vitro
(data to be published elsewhere); and (iii) the GBV-B
30-UTR adopts a dimeric conformation in the presence of
GBV-B core, similarly to HCV (data to be published
elsewhere).
A possible consequence of dimerization may be the facil-
itation of recombination between various HCV genotypes
and subtypes, leading to increased viral variability, as it is
well documented in retroviruses (73,74). To our knowledge,
this is the ﬁrst description of an RNA virus whose genome
may dimerize—and thus might undergo recombination by a
copy-choice mechanism—both in the positive-strand and
the replicative negative-strand forms. Reports of circulating
recombinant HCV strains (75–77) demonstrate that superin-
fection and recombination do occur in natural populations,
although their frequency and their determinants are still
poorly understood.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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